Igm Biosciences earnings were -$219.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest IGMS earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$61.4M, up 28.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IGMS reported annual earnings of -$246.4M, with 11.4% growth. The next IGMS earnings date is Mar 5, 2025.
What were Igm Biosciences's earnings last quarter?
On IGMS's earnings call on Invalid Date, Igm Biosciences (NASDAQ: IGMS) reported Q3 2024 earnings per share (EPS) of -$1.01, up 2.88% year over year. Total IGMS earnings for the quarter were -$61.43 million. In the same quarter last year, Igm Biosciences's earnings per share (EPS) was -$1.04.
The next IGMS earnings call is Invalid Date. Add IGMS to your watchlist to be reminded of Igm Biosciences's next earnings date.
What was IGMS's earnings growth in the past year?
As of Igm Biosciences's earnings date in Invalid Date, Igm Biosciences's earnings has grown year over year. IGMS earnings in the past year totalled -$219.84 million.
Is Igm Biosciences profitable or losing money?
As of the last Igm Biosciences earnings report, Igm Biosciences is currently losing money. Igm Biosciences's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$219.84 million, a 7.74% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.